Chapter 1 .- Introduction.- Chapter 2 25+ Observations over 25+ years for Surviving & Thriving in the Dietary Supplement Quality Control &/or Perception vs. Reality World.- Chapter 3.- The Ideal 7-Step Breast Cancer Diet, Lifestyle & Dietary Supplements Program for Prevention/Recurrence: Heart Healthy=Breast Healthy.- Chapter 4.- S.A.M & Breast Cancer-Focus on Statins, Red Yeast Rice, Sterols & Other Integrative Cholesterol Medicines: The Real “Natural” Options.- Chapter 5 S.A.M. & BREAST CANCER-Focus on Aspirin & Other Integrative Aspirin-like Medicines: The Real “Natural” Options.- Chapter 6 S.A.M. & BREAST CANCER-Focus on Metformin & Other Integrative Metformin-Mimic Medicines: The Real “Natural” Options.- Chapter 7 Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What helps, harms, or does nothing.- Chapter 8 Supplements/Diet/Other Integrative Method Vernacular & Controversies from A to Z: What is the latest or greatest, or not so great.
Mark A. Moyad, MD, MPH, Ann Arbor, MI
This book is designed to capture and clinically review the comprehensive database of clinical research articles that support and do not support the utilization of a variety of dietary supplements and other complementary medicines that physicians are exposed to in their daily practice. The growing list of CAM products that could interfere with surgery (anesthesia, bleeding, outcomes…) and/or conventional medicines is very large and is provided in each section of the book. Additionally, the list of dietary supplements that could be utilized to improve quality of life for breast cancer patients is also emphasized. The various sub-specialty groups in breast are adequately represented, which allows for a physician to rapidly and thoroughly investigate their topic of interest regardless of whether the topic is prevention, treatment, or a specific side effect of treatment.
The practical nature of this book cannot be overstated. Chapters include a general overview of the CAM agent, whether or not it has data in medicine and oncology, and a list of potential drug interactions and specific clinical scenarios where it can be utilized or discouraged in the specialty. Each chapter also includes a rapid review A to Z table that covers the clinical take home points for each subject reviewed in each chapter.